To further elucidate possible mechanisms that could influence differential SMAD4 promoters' activity in CRC, we performed in silico analysis of promoters C and D and the pull-down assay coupled with mass spectrometry to validate the results of in silico analysis. Here, SMAD4 is linked to colorectal carcinoma.